Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,192,475,293
+$842,667,403 QoQ
Shares Held
10,998,953
-18.1% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
2.30%
of 13F equity value
Holder Rank
#16
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 96%
None 4%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $41,461,553,100 across 12 Drug Manufacturers - General names. LLY ranks #1 (31.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
10,998,953 | $13,192,475,293 | |
| 2 | MRK |
Merck & Co., Inc.
|
86,249,283 | $11,083,032,864 | |
| 3 | JNJ |
Johnson & Johnson
|
22,588,696 | $5,736,851,118 | |
| 4 | AZN |
Astrazeneca PLC
|
28,537,243 | $5,411,232,013 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,699,683 | $1,604,477,945 | |
| 6 | ABBV |
AbbVie Inc.
|
5,055,589 | $1,272,188,413 | |
| 7 | AMGN |
Amgen Inc
|
2,742,271 | $993,031,171 | |
| 8 | BIIB |
Biogen Inc.
|
3,117,469 | $673,560,350 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,192,475,293 | 10,998,953 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,349,807,890 | 13,427,061 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,354,700,908 | 13,357,185 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,112,164,140 | 14,563,780 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,905,274,687 | 13,989,551 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,495,261,231 | 12,707,512 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,747,214,100 | 12,625,925 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $9,403,186,424 | 10,613,796 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $9,759,173,405 | 10,779,091 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,570,106,157 | 11,016,127 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,866,696,167 | 11,779,826 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $6,904,518,780 | 12,854,465 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,777,374,890 | 14,451,309 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,979,759,767 | 20,324,267 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,320,428,397 | 20,009,918 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,063,027,171 | 21,843,288 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,599,061,507 | 23,437,256 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,795,942,146 | 27,223,320 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,536,465,750 | 27,284,287 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $6,557,676,346 | 28,382,066 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,007,284,154 | 30,530,168 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,938,817,052 | 31,788,979 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,596,767,748 | 33,148,352 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,747,546,968 | 25,317,842 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $4,431,345,926 | 26,990,778 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,997,180,888 | 36,023,507 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||